🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Self-tonometry with iCare Home is regularly performed at Sankt Erik's Eye H...
Status
Completed
Location
St Erik Eye Hospital
Start Date
2020-04-01
Trial ID
NCT04911387
Treatments Being Tested
Primary congenital glaucoma (PCG) is a vision-threatening disorder of child...
Status
Completed
Location
Benha University
Start Date
2022-01-01
Trial ID
NCT07701278
Treatments Being Tested
This is a prospective, multicenter, single-arm clinical study to evaluate t...
Status
Terminated
Location
Icon Eye Care
Start Date
2020-04-29
Trial ID
NCT04072016
Treatments Being Tested
This is a pilot, open-label, multi-center clinical study. Each potential su...
Status
Completed
Location
Stiles Eyecare Excellence
Start Date
2021-09-08
Trial ID
NCT04962009
Treatments Being Tested
The aim of this clinical study is to provide information about the variabil...
Status
Completed
Location
East West Eye Institute
Start Date
2021-11-26
Trial ID
NCT05162989
Treatments Being Tested
This randomized controlled trial evaluated whether a single drop of 0.5% ti...
Status
Completed
Location
CMH Institute of Medical Sciences
Start Date
2025-03-10
Trial ID
NCT07729189
Treatments Being Tested
Aim: Evaluation of a single subconjunctival injection of liposomal EggPC fo...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01987323
Treatments Being Tested
This study will quantify the intraocular pressure elevation in the immediat...
Status
Completed
Location
Retina Support Services, Inc
Start Date
2007-01
Trial ID
NCT00417703
The purpose of this study is to evaluate the effect of child delivery on th...
Status
Completed
Location
Meir Medical Center
Start Date
2010-08
Trial ID
NCT01174342
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160